Summary
In comparison to most other groups with intellectual disability individuals with Down syndrome are at lower risk for significant psychopathology, although relative to their typically developing peers they have higher rates of behavioural and emotional problems. A total of 43 Down syndrome patients (21 females and 22 males), who ranged in age from 5.33 to 30.58 years, were examined for the presence of age-related changes in the spectrum of externalizing and internalizing problems. Intelligence tests included Hamburg-Wechsler-Intelligenz Test für Kinder III (HAWIK-III), HamburgWechsler-Intelligenz Test für Erwachsene (HAWIE-R) and KaufmanAssessment-Battery for Children, German Version (K-ABC). Behavioural and emotional problems were assessed by the the Strengths and Difficulties Questionnaire for Parents, German Version (SDQ) and the Clinical Assessment Scale for Child and Adolescent Psychopathology (CASCAP). IQ was significantly inversly related to the age of patients. Externalizing behaviours (dominant, opposing/refusing, impulsiveness, inattention and increased motor activity) were significantly higher in the 5–10 years old group, whereas internalizing behaviours (shy/insecure, low selfconfidence, decreased motor activity) where more prevalent in adolescents and adults (10–30 years). Possible relationships between this age-related changes and increased risks of later-onset psychopathology (depression and dementia) are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aylward E, Burt D, Thorpe L, Lai F, Dalton A (1997) Diagnosis of dementia in individuals with intellectual disability: report of the task force for development of criteria for diagnosis of dementia in individuals with mental retardation. J Intellect Disabil Res 41: 152–164
Bazelon M, Paine RS, Coeiw VA, Hunt P, Houck JC, Mahanand D (1967) Reversal of hypotonia in infants with Down’s syndrome by administration of 5hydroxytryptophan. Lancet i: 1130–1133
Burt D, Loveland K, Primeaux-Hart S, Chen Y, Phillips N, Cleveland L, Lewis K, Lesser J, Cummings E (1998) Dementia in adults with Down Syndrome: diagnostic challenges. Am J Ment Retard 103: 130–145
Coe DA, Matson JL, Russell DW, Slifer KJ, Capone GT, Baglio C, Stallings S (1999) Behavior problems of children with Down syndrome and life events. J Autism Dev Disord 29: 149–156
Coleman M (1971) Infantile spasms associated with 5-hydroxytryptophan administered in patients with Down’s syndrome. Neurol 21: 911–919
Collacott RA (1999) People with Down syndrome and mental health needs. In: Bouras N (ed) Psychiatric and behavioural disorders in developmental disabilities and mental retardation. Cambridge University Press, Cambridge, pp 200–211
Collacott RA, Cooper S, McGrother C (1992) Differential rates of psychiatric disorders in adults with Down’s syndrome compared to other mentally handicapped adults. Br J Psychiatry 161: 671–674
Collacott RA, Cooper SA, Branford D, McGrother C (1998) Behaviour phenotype for Down’s syndrome. Br J Psychiatry 172: 85–89
Cooper SA, Prasher VP (1998) Maladaptive behaviours and symptoms of dementia in adults with Down’s syndrome compared with adults with intellectual disability of other aetiologies. J Intellect Disabil Res 42: 293–300
Cuskelly M, Dadds M (1992) Behavioural problems in children with Down’s syndrome and their siblings. J Child Psychol Psychiatry 33: 749–761
Cuskelly M, Gunn P (1997) Behavior concerns. In: Pueschel SM, Sustrova M (eds) Adolescents with Down Syndrome. Paul H. Brookes, Baltimore London Toronto Sydney, pp 111–127
Dalton A (1992) Dementia in Down syndrome: methods of evaluation. In: Nadel L, Epstein C (eds) Down Syndrome and Alzheimer disease. Wiley-Liss, New York, pp 51–76
Döpfner M, Berner W, Flechtner H, Lehmkuhl G, Steinhausen H-C (1999) Clinical Assessment Scale for Child and Adolescent Psychopathology. Hogrefe, Göttingen Bern Toronto Seattle
Dykens EM, Kasari C (1997) Maladaptive behaviour in children with Prader-Willi syndrome, Down syndrome, and non-specific mental retardation. Am J Ment Retard 102: 228–237
Dykens EM, Hodapp RM, Evans DW (1994) Profiles and development of adaptive behavior in children with Down syndrome. Am J Ment Retard 98: 580–587
Dykens EM, Shah B, Sagun J, Beck T, King BH (2002) Maladaptive behaviour in children and adolescents with Down’s syndrome. J Intellect Disabil Res 46: 484–492
Einfeld SL, Tonge BJ (1996) Population prevalence of psychopathology in children and adolescents with intellectual disability. II. Epidemiological findings. J Intellect Disabil Res 40: 99–109
Epstein CJ (1995) Down Syndrome (Trisomy 21). In: Scriver SR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 749–794
Frankenburg WK, Dodds JB (1990) Denver II developmental screening test. In: Stanhope M, Knollmueller RN (1992) Handbook of community and home health-nursing: tools for assessment intervention and education. Mosby, St. Louis, pp 317–319
Gath A, Gumley D (1986) Behaviour problems in retarded children with special reference to Down’s syndrome. Br J Psychiatry 149: 156–161
Gath A, Gumley D (1987) Retarded children and their siblings. J Child Psychol Psychiatry 5: 715–730
Gedye A (1990) Dietary increase in serotonin reduces self-injurious behaviour in a Down’s syndrome adult. J Ment Defic Res 34: 195–203
Gedye A (1991) Serotonergic treatment of aggression in a Down’s syndrome adult showing signs of Alzheimer’s disease. J Ment Defic Res 35: 247–258
Geldmacher DS, Lerner AJ, Voci JM, Noelker EA, Somple LC, Whitehouse PJ (1997) Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs. J Geriatr Psychiat Neurol 10: 99–104
Gibson D, Groenewez G, Jerry P, Harris A (1988) Age and pattern of intellectual decline among Down Syndrome and other mentally retarded adults. Int J Rehabil Res 11: 47–55
Godridge H, Reynolds GP, Czudek C, Calcutt NA, Benton M (1987) Alzheimer-like neurotransmitter deficits in adult Down’s syndrome brain tissue. J Neurol Neurosurg Psychiatry 50: 775–778
Goodman R (1997) The strengths and difficulties questionnaire for parents, German version. J Child Psychol Psychiatry 38: 581–586
Haxby JV (1989) Neuropsychological evaluation of adults with Down’s syndrome: patterns of selective impairment in nondemented old adults. J Ment Defic Res 33: 193–197
Haxby JV, Schapiro MB (1992) Longitudinal study of neuropsychological functions in older adults with Down syndrome. In: Epstein C, Nadel L (eds) Down syndrome and Alzheimer disease. Wiley Liss, New York, pp 35–50
Helmstaedter C, Lendt M, Lux S (2001) Verbaler Lern-and Merkfähigkeitstest. Beltz, Göttingen
Holland AJ, Hon J, Huppert FA, Stevens F, Watson P (1998) Population based study on the prevalence and presentation of dementia in adults with Down’s syndrome. Br J Psychiatry 172: 493–498
Holland AJ, Hon J, Huppert FA, Stevens F (2000) Incidence and course of dementia in people with Down’s syndrome: findings from a population-based study. J Intellect Disabil Res 44: 138–146
Johnson J, Head E, Kim R, Starr A, Cotman C (1999) Clinical and pathological evidence for a frontal variant of Alzheimer’s disease. Arch Neurol 56: 1233–1239
Lai F, Williams R (1989) A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46: 849–853
Lai F, Kammann E, Rebeck GW, Anderson A, Chen Y, Nixon RA (1999) APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome. Neurol 53: 331–336
Maluck A, Melchers P (1998) Kaufman Assessment Battery for Children. Differential evaluation of (partial) intellectual ability of mentally handicapped adults. Nervenarzt 69: 1007–1014
Mann DM, Yates PO, Marcyniuk B, Rawndra CR (1985) Pathological evidence for neurotransmitter deficits in Down’s syndrome of middle age. J Ment Defic Res 29: 125–135
McCarthy J, Boyd J (2001) Psychopathology and young people with Down’s syndrome: childhood predictors and adult outcome of disorder. J Intellect Disabil Res 45: 99–105
Melchers P, Preuß U (1991) Kaufman-Assessment-Battery for Children, German Version. Swets & Zeitlinger, Amsterdam
Myers BA (1997) Psychiatric disorders. In: Pueschel SM, Sustrova M (eds) Adolescents with Down Syndrome. Paul H. Brookes, Baltimore London Toronto Sydney, pp 129–142
Myers BA, Pueschel SM (1991) Psychiatric disorders in population with Down syndrome. J New Ment Dis 179: 609–613
Nelson LD, Orme D, Osann K, Lott IT (2001) Neurological changes and emotional functioning in adults with Down Syndrome. J Intellect Disabil Res 45: 450–456
Pietrini P, Alexander GE, Furey ML, Hampel H, Guazelli M (2000) The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer’s disease. Int J Psychophysiol 37: 87–98
Pueschel SM, Bernier JC, Pezzullo JC (1991) Behavioural observations in children with Down’s syndrome. J Ment Defic Res 35: 502–511
Risser D, Lubec G, Cairns N, Herrera-Marschitz M (1997) Excitatory amino acids and monoamines in parahippocampal gyrus and frontal cortical pole of adults with Down syndrome. Life Sci 60: 1231–1237
Rutter M, Tizard J, Yule W, Graham P, Whitmore K (1976) Research report: Isle of Wight Studies, 1964–1974. Psychol Med 6: 313–332
Seidl R, Kaehler ST, Prast H, Singewald N, Cairns N, Gratzer M, Lubec G (1999) Serotonin (5-HT) in brains of adult patients with Down syndrome. J Neural Transm [Suppl] 57: 221–232
St.Clair DF, Blackwood D (1985) Premature senility in Down’s syndrome. Lancet 6: 34
Stores R, Stores G, Fellows B, Buckley S (1998) Daytime behaviour problems and maternal stress in children with Down’s syndrome, their siblings, and non-intellectually disabled and other intellectually disabled peers. J Intellect Disabil Res 42: 228–237
Tewes U (1994) Hamburg-Wechsler-Intelligenztest für Erwachsene. Huber, Bern Göttingen Toronto Seattle
Tewes U, Rossmann P, Schallberger U (2000) Hamburg-Wechsler-Intelligenz Test für Kinder I II. Huber, Bern Göttingen Toronto Seattle
Turner S, Sloper P (1996) Behaviour problems among children with Down’s Syndrome: prevalence, persistence and parental appraisal. J Appl Res Intellect Disabil 9: 129–144
Tyrrell J, Cosgrave M, McCarron M, McPherson J, Calvert J, Kelly A, McLaughlin M, Gill M, Lawlor BA (2001) Dementia in people with Down’s syndrome. Int J Geriatr Psychiatry 16: 1168–1174
Visser FE, Aldenkamp AP, van Huffelen AC, et al. (1997) Prospective study of the prevalence of Alzheimer-type dementia in institutionalised individuals with Down syndrome. Am J Ment Retard 101: 400–412
Warren AC, Holroyd S, Folstein P (1989) Major depression in Down’s syndrome. Br J Psychiatry 155: 202–207
Warren AC, Holroyd S, Folstein MP (1990) Mayor depression in Down’s syndrome. Br J Psychiatry 155: 202–205
Weise P, Koch R, Shaw KNF, Rosenfeld MJ (1974) The use of 5-HTP in the treatment of Down’s syndrome. Pediatr 54: 165–167
Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down syndrome. Ann Neurol 17: 278–282
Yates CM, Simpson J, Gordon A (1986). Regional brain 5-hydroxytryptamine levels are reduced in senile Down’s syndrome as in Alzheimer’s disease. Neurosci Lett 65: 189–192
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag
About this chapter
Cite this chapter
Nicham, R. et al. (2003). Spectrum of cognitive, behavioural and emotional problems in children and young adults with Down syndrome. In: Lubec, G. (eds) Advances in Down Syndrome Research. Journal of Neural Transmission Supplement 67, vol 67. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6721-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6721-2_16
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-40776-9
Online ISBN: 978-3-7091-6721-2
eBook Packages: Springer Book Archive